【传EQT提议以超50美元/股收购快而精医药(QGEN.US) KKR亦参与竞购】智通财经APP获悉,知情人士透露,瑞典私募股权公司EQT
AB正在就收购欧洲分子检测公司快而精医药(QGEN.US)进行深入谈判,并已提交每股超过50美元的约束性报价。知情人士还称,另一家私募股权巨头KKR也参与了竞购。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.